Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $825.38 billion, total revenue of $166.46 billion and a weighted average PE ratio of 53.43.
Market Cap
825.38B
Revenue
166.46B
Profits
15.45B
PE Ratio
53.43
Profit Margin
9.28%
Dividend Yield
0.18%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 232.51B | 2.04% | 2,268,399 | 43.74B |
| 2 | DHR | Danaher Corporation | 168.37B | 1.43% | 2,497,331 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 56.96B | 0.13% | 500,602 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 42.11B | 1.89% | 1,786,269 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 41.28B | -0.32% | 1,262,537 | 15.90B |
| 6 | NTRA | Natera, Inc. | 32.41B | -2.19% | 978,548 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 30.34B | 1.36% | 140,572 | 3.94B |
| 8 | WAT | Waters Corporation | 23.62B | 0.03% | 471,447 | 3.11B |
| 9 | ILMN | Illumina, Inc. | 21.56B | -3.26% | 1,885,959 | 4.29B |
| 10 | LH | Labcorp Holdings Inc. | 20.88B | -1.12% | 502,154 | 13.77B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.41B | -1.86% | 925,085 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.38B | 0.32% | 1,541,515 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.76B | -0.84% | 186,007 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 14.19B | 1.32% | 2,396,726 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 13.85B | -3.63% | 1,419,491 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 11.84B | 2.67% | 1,135,780 | 2.81B |
| 17 | CRL | Charles River Laboratories International, Inc. | 10.87B | 2.51% | 1,127,111 | 4.02B |
| 18 | QGEN | Qiagen N.V. | 9.95B | -0.33% | 1,262,713 | 2.07B |
| 19 | RDNT | RadNet, Inc. | 6.04B | -0.23% | 694,087 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.45B | 2.07% | 5,616,106 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 3.93B | -1.88% | 197,318 | 254.14M |
| 22 | WGS | GeneDx Holdings Corp. | 3.91B | -1.52% | 460,863 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.90B | 2.10% | 529,903 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.32B | -3.49% | 1,128,346 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 2.16B | 1.67% | 852,063 | 376.57M |
| 26 | NEOG | Neogen Corporation | 2.09B | -0.93% | 9,381,277 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.70B | 2.57% | 1,286,081 | 709.16M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.15B | -1.38% | 332,420 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.04B | -0.73% | 2,360,866 | 642.07M |
| 30 | CDNA | CareDx, Inc. | 881.04M | -0.52% | 546,714 | 358.00M |
| 31 | FLGT | Fulgent Genetics, Inc. | 860.91M | -0.14% | 224,415 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 719.32M | -3.34% | 1,162,591 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 613.35M | 0.30% | 844,905 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 261.35M | -7.28% | 218,459 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 250.86M | -0.43% | 17,821 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 213.26M | -0.80% | 42,256 | 4.40M |
| 37 | MDXH | MDxHealth SA | 161.36M | -0.31% | 76,458 | 103.07M |
| 38 | XGN | Exagen Inc. | 143.68M | 2.76% | 428,967 | 63.60M |
| 39 | FONR | FONAR Corporation | 121.53M | - | 44,338 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 43.44M | -2.15% | 42,445 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.40M | 7.28% | 13,242 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 20.87M | -3.77% | 181,065 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.69M | 0.43% | 492,294 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 10.30M | 0.57% | 27,376 | - |
| 45 | ADVB | Advanced Biomed Inc. | 7.77M | 1.24% | 32,827 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 5.97M | 3.10% | 42,432 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 5.42M | 0.65% | 13,604 | - |
| 48 | ISPC | iSpecimen Inc. | 2.99M | -6.94% | 542,829 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.58M | -2.89% | 49,358 | 29.52M |